Literature DB >> 17229

Drugs for peptic ulcer.

C G Clark, J H Wyllie.   

Abstract

Conservative management of peptic ulcer relies on the use of drugs as an adjuvant to the time-honored measures of avoiding stress, reducing gastric secretion, and regulating the diet. Alkalies neutralize acid and anticholinergic drugs partly inhibit secretion.. Both are widely used but are often inadequate to control symptoms. Carbenoxolone appears to have a more specific effect in promoting healing of gastric ulcers and has now been used for 15 years. Its role in the treatment of gastric ulcer can be critrically examined, particularly in relation to how this influences surgical management. Recently introduced compounds know as histamine H2-receptor antagonists have a profound effect in inhibiting gastric secretion. Early experience in patients with duodenal ulcer indicated the efficacy of these compounds in promoting healing. These potent new drugs are likely to influence strongly the management of patients with duodenal ulcer, and this may affect the indications for surgery.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17229

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

1.  Triterpenoid liquorice compound in gastric and duodenal ulcer.

Authors:  R DOLL; I D HILL
Journal:  Lancet       Date:  1962-12-01       Impact factor: 79.321

2.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

3.  Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide.

Authors:  G J Milton-Thompson; J G Williams; D J Jenkins; J J Misiewicz
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

4.  Letter: Neutropenia associated with metiamide.

Authors:  J A Forrest; D J Shearman; R Spence; L R Celestin
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

5.  Quantitative and qualitative aspects of the plasma protein binding of carbenoxolone, an ulcer-healing drug.

Authors:  D V Parke; W E Lindup
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

6.  Metiamide--an orally active histamine H2-receptor antagonist.

Authors:  J W Black; W A Duncan; J C Emmett; C R Ganellin; T Hesselbo; M E Parsons; J H Wyllie
Journal:  Agents Actions       Date:  1973-10

7.  Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine.

Authors:  W L Burland; P C Sharpe; D G Colin-Jones; P R Turnbull; P Bowskill
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  Healing of gastric ulcer during treatment with cimetidine.

Authors:  R E Pounder; R H Hunt; M Stekelman; G J Milton-Thompson; J J Misiewicz
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

9.  Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man.

Authors:  D C Carter; J A Forrest; M Werner; R C Heading; J Park; D J Shearman
Journal:  Br Med J       Date:  1974-08-31

10.  Cimetidine in the treatment of active duodenal and prepyloric ulcers.

Authors:  G Bodemar; A Walan
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

View more
  2 in total

1.  Cimetidine and the gastric surgeon.

Authors:  C G Clark; P B Boulos
Journal:  World J Surg       Date:  1979-11       Impact factor: 3.352

2.  Drugs for peptic ulcer.

Authors:  F A Jones; T Hunt
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.